Skip to content
Norton & Elaine Sarnoff Center for Jewish Genetics Logo
  • Home
  • Get Screened
  • About Us
    • Board Members
    • Staff
  • Genetic Disorders
    • Types of Genetic Disorders
    • Jewish Genetic Disorder FAQs
    • Rabbinical Insights
  • Hereditary Cancer
    • BRCA Mutations
    • Lynch Syndrome
    • Assess Your Risk
    • Cancer FAQs
    • Cancer Resources
  • Resources
    • Preimplantation Genetic Testing
    • Family Health History
    • Teach Jewish Genetics
    • Community Resources
    • Educational Brochures
    • For Medical Professionals
    • Personal Stories
    • Blog
  • Get Involved
    • Events
    • Donate
Previous Next

POMGNT1-Related Disorders

POMGNT1-related disorders, a group of muscular dystrophy-dystroglycanopathies (MDDG) vary in severity and impact several different parts of the body.

Muscular Dystrophy-Dystroglycanopathy Type A3 (MDDGA3): This includes Walker-Warburg syndrome (WWS) and muscle-eye-brain disease (MEB). It causes significant muscle weakness, vision problems, brain changes, and severe intellectual disabilities. Children may feel floppy in infancy and struggle with motor skills in childhood. Eye issues like near-sightedness and glaucoma are common. Brain abnormalities include fluid buildup and underdeveloped brainstem. Seizures and intellectual disability are expected, with varying severity. Most individuals have severe effects, leading to shortened lifespans.

Muscular Dystrophy-Dystroglycanopathy Type B3 (MDDGB3): Also known as Fukuyama congenital muscular dystrophy (FCMD), it causes significant and progressive muscle weakness, generally less severe than MDDGA3. Some children may eventually walk. Eye problems are variable but milder than MDDGA3. Developmental delays, moderate intellectual disability, seizures, and brain changes are common.

Muscular Dystrophy-Dystroglycanopathy Type C3 (MDDGC3): Referred to as limb-girdle muscular dystrophy (LGMD) type 20, it is the mildest of POMGNT1-related disorders. Symptoms include weakness in muscles close to the body’s center, affecting shoulders, upper arms, pelvic area, and thighs. The weakness is progressive but may vary. The brain and eyes are not affected, and intelligence and lifespan are typically normal.

There is no cure for these disorders. Treatments focus on symptom management, including physical and occupational therapy, vision services, glasses, and medication for seizures.

This group of conditions is caused by pathogenic (disease-causing) variants in the POMGNT1 gene and exhibits autosomal recessive inheritance. This means that both parents must be carriers to have a 25% chance to have a child with the condition. The risk of being a carrier is based on a person’s ancestry or ethnic background.

Resources:  

Medline Plus – Fukuyama Congenital Muscular Dystrophy

Medline Plus – Limb Girdle Muscular Dystrophy

Medline Plus – Walker-Warburg Syndrome

Revised November 2023

Scott Weissman2023-11-16T16:25:09+00:00November 16, 2023|

Share This Story, Choose Your Platform!

FacebookXRedditLinkedInWhatsAppTumblrPinterestVkXingEmail

About the Author: Scott Weissman

The Norton & Elaine Sarnoff Center for Jewish Genetics is a supporting foundation of the Jewish United Fund, and is supported in part by the Michael Reese Health Trust.

30 S Wells
Chicago, IL 60606
312-357-4718
jewishgenetics@juf.org

About
  • About Us
  • Genetic Disorders
  • Hereditary Cancer
  • Donate
Resources
  • Medical Professionals
  • Teach Jewish Genetics
  • Events

©2025 Norton & Elaine Sarnoff Center for Jewish Genetics

Page load link
Go to Top